BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Business

  Global Dermatology Leader Galderma Opens Office In Dubai

  November 23, 2015

   · 

  1 min read
• Bactiguard Holding AB (publ): Growing Interest In Infection Prevention In The Middle East

  November 23, 2015

   · 

  1 min read
• Business

  Zai Lab And Hanmi Pharma Execute A License Agreement To Develop Novel EGFR Targeted Therapy For Lung Cancer In China

  November 23, 2015

   · 

  1 min read
• Accuitis, Inc. Completes Latest Financing Round And Elects Geoffrey Meacham PhD To Board Of Directors

  November 23, 2015

   · 

  1 min read
• Lone Star Bio

  Mirna Announces The Publication Of New Data Supporting Potential Immune-Related Mechanism For Anti-Cancer Activity Of MRX34

  November 23, 2015

   · 

  5 min read
• BioMidwest

  Baxalta Receives Positive CHMP Opinion For Use Of ONCASPAR (Pegaspargase) In European Union As A Component Of Combination Therapy In Acute Lymphoblastic Leukaemia (ALL)

  November 23, 2015

   · 

  5 min read
• Biotech Bay

  European Commission (EC) Grants Marketing Authorization For Gilead’s Single Tablet Regimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofovir Alafenamide) For The Treatment Of HIV-1 Infection

  November 23, 2015

   · 

  6 min read
• Biotech Bay

  Genentech Release: Updated Data Showed Cotellic In Combination With Zelboraf Helped People With A Specific Type Of Advanced Melanoma Live Significantly Longer Than With Zelboraf Alone

  November 23, 2015

   · 

  15 min read
• Drug Development

  Merck & Co. Announces Initial Results For KEYTRUDA (Pembrolizumab) With Novel Immunotherapy Combinations From Three Investigational Studies Presented At The Society For Melanoma Research International Congress

  November 23, 2015

   · 

  19 min read
• FDA

  Adding Multimedia U.S. FDA Approves Takeda’s Ninlaro(Ixazomib), The First And Only Oral Proteasome Inhibitor To Treat Multiple Myeloma

  November 23, 2015

   · 

  10 min read